Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Sven Ullman
Age : 65
Public asset : 502,621 USD
Country of residence : Unknown
Linked companies : Swedish Orphan Biovitrum AB (publ) - Verona Pharma plc

Summary 
Presently, Sven Anders Ullman holds the position of Chief Medical Officer, Head-Research & Development at Swedish Orphan Biovitrum AB.

He is also on the board of Verona Pharma Plc and Zydus Nycomed Healthcare Pvt Ltd.

In his past career he held the position of Executive VP, Head-Research & Development at Baxter International, Inc. and Head-Research & Development at Baxter BioScience Corp. (a subsidiary of Baxter International, Inc.), Head-COPD Center at Sahlgrenska Universitetssjukhuset, Member-Executive Management at Nycomed Asset Management GmbH, Chief Scientific Officer & SVP-Research at Biovitrum AB, Executive Vice President-Research & Development at Takeda A, EVP & Director-Research & Development at Takeda Pharmaceuticals International AG, Director at Nycomed Pharma Pvt Ltd., Medical Manager at The Upjohn Co., Executive Vice President for Bayer HealthCare AG, Head-Human Pharmacology at Astra Draco AB and Member-Executive Management at Nycomed GmbH.

Dr. Ullman received a doctorate from the University of Gothenburg.




Current positions of Sven Ullman 
Holdings of Sven Ullman 
Sven Ullman : Personal Network 
Most Read News 
09/13Ark's Cathie Wood calls Fed hikes a mistake and preps for deflation
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/14Package that exploded in Boston had note critical of Meta's Zuckerberg, CNN reports
RE
09/13Inditex founder Amancio Ortega to buy U.S. warehouses for $905 million
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/14Kuehne: have raised stake in Lufthansa to 17.5%
RE
More news


© 2022 People and Ownership :   
Sven Ullman : Connections 


Latest news about Sven Ullman 
- No news -
More news